Citius Pharmaceuticals Inc (CTXR)
0.1345
-0.03
(-18.53%)
USD |
NASDAQ |
Nov 22, 16:00
0.133
0.00 (0.00%)
After-Hours: 19:59
Citius Pharmaceuticals Total Liabilities (Quarterly): 10.81M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 10.81M |
| March 31, 2024 | 10.74M |
| December 31, 2023 | 12.07M |
| September 30, 2023 | 12.18M |
| June 30, 2023 | 12.10M |
| March 31, 2023 | 12.43M |
| December 31, 2022 | 10.67M |
| September 30, 2022 | 10.57M |
| June 30, 2022 | 9.980M |
| March 31, 2022 | 9.59M |
| December 31, 2021 | 12.96M |
| September 30, 2021 | 9.646M |
| June 30, 2021 | 9.311M |
| March 31, 2021 | 8.904M |
| December 31, 2020 | 9.511M |
| September 30, 2020 | 10.10M |
| June 30, 2020 | 9.658M |
| March 31, 2020 | 4.049M |
| December 31, 2019 | 4.606M |
| September 30, 2019 | 9.594M |
| June 30, 2019 | 4.038M |
| March 31, 2019 | 3.361M |
| December 31, 2018 | 3.900M |
| September 30, 2018 | 3.185M |
| June 30, 2018 | 2.190M |
| Date | Value |
|---|---|
| March 31, 2018 | 2.562M |
| December 31, 2017 | 2.617M |
| September 30, 2017 | 2.469M |
| June 30, 2017 | 9.973M |
| March 31, 2017 | 7.342M |
| December 31, 2016 | 6.319M |
| September 30, 2016 | 5.184M |
| June 30, 2016 | 4.854M |
| March 31, 2016 | 4.353M |
| December 31, 2015 | 1.937M |
| September 30, 2015 | 1.377M |
| June 30, 2015 | 2.143M |
| March 31, 2015 | 1.684M |
| December 31, 2014 | 1.646M |
| September 30, 2014 | 2.299M |
| June 30, 2014 | 0.0314M |
| March 31, 2014 | 0.0251M |
| December 31, 2013 | 0.021M |
| September 30, 2013 | 0.0147M |
| June 30, 2013 | 0.062M |
| March 31, 2013 | 0.0576M |
| December 31, 2012 | 0.0474M |
| September 30, 2012 | 0.046M |
| June 30, 2012 | 0.0406M |
| March 31, 2012 | 0.0336M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.049M
Minimum
Mar 2020
12.96M
Maximum
Dec 2021
9.994M
Average
10.10M
Median
Sep 2020
Total Liabilities (Quarterly) Benchmarks
| Citius Oncology Inc | -- |
| Agilent Technologies Inc | 5.093B |
| Merck & Co Inc | 72.97B |
| Cara Therapeutics Inc | 50.62M |
| Moleculin Biotech Inc | 15.92M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 97.09M |
| Shareholders Equity (Quarterly) | 85.68M |